UT Health San Antonio
Category ID
171

Multimillion-dollar NIH grant to boost innovative ovarian cancer drug development

<p>The Mays Cancer Center at UT Health San Antonio and local partner Evestra Inc. have been awarded a five-year, $3.3 million Academic Industry Partnership grant from the National Institutes of Health (NIH). It is the first grant of this kind awarded to UT Health San Antonio.</p>

Share This Story

Robotic kidney cancer surgery shows desirable outcomes in study

<p>In a study featured on the cover of the Journal of Urology (Official Journal of the American Urological Association), researchers from the Mays Cancer Center and Department of Urology show that robotically removing cancer from the inferior vena cava is a safe and effective alternative to the standard open surgery for kidney cancer.</p>

Share This Story

Welcome to our new Senior Director of Finance and Administration

<p>Paymon Bagheri has joined the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, as the senior director of finance and administration. Paymon is a Fellow of the American College of Healthcare Executives (FACHE), Fellow of the American College of Medical Practice Executives (FACMPE) and a certified Lean Six Sigma health [&hellip;]</p>

Share This Story

Oral pill improves care of patients with bone marrow cancer: Study

<p>Momelotinib, an oral pill taken once a day, significantly improved outcomes of patients treated for myelofibrosis (MF), a rare but fatal bone marrow cancer, researchers reported June 7.&nbsp;Ruben Mesa, MD, FACP, executive director of the&nbsp;Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, presented results of the MOMENTUM phase 3 randomized [&hellip;]</p>

Share This Story

Ivanhoe.com: Fast tracked leukemia drug saves lives

<p>Dr. Ruben Mesa, executive director of the Mays Cancer Center, is shown in an interview he gave this spring that recently appeared on stations nationwide. Watch Video</p>

Share This Story

UT Health San Antonio surgical oncologist co-authors NEJM article showing disparity in Black breast cancer mortality

<p>Black women die of breast cancer at rates nearly 40% higher than white women, despite having lower instances of the disease, because of racial disparities in care, according to a New England Journal of Medicine article by a UT Health San Antonio surgical oncologist and two American Cancer Society scientists. The authors, led by Ismail [&hellip;]</p>

Share This Story

Welcoming our new chief of surgical oncology

<p>Alexander Parikh MD, MPH, FACS, FSSO, has joined the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center as chief of surgical oncology in the Division of Surgical Oncology and Endocrine Surgery. Dr. Parikh is a professor of surgery and holds the Paige Johnson Distinguished Chair of Oncology and is the [&hellip;]</p>

Share This Story

KXAN-TV, Austin: Susan G. Komen® invests $21.7 million in research focused on improving outcomes for breast cancer patients

<p>Dr. Amelie G. Ramirez, Population Health Sciences and Institute for Health Promotion Research, is listed as a grant winner in this article. &nbsp; Read More</p>

Share This Story

Pheo Para Alliance recognizes UT Health San Antonio as rare disease Center of Excellence

<p>Pheo Para Alliance, a patient advocacy organization dedicated to supporting those with pheochromocytoma (pheo) and paraganglioma (para), a rare neuroendocrine tumor, has designated The University of Texas Health Science Center at San Antonio (UT Health San Antonio) as a Pheo Para Center of Excellence. The Center of Excellence Program recognizes institutions worldwide for providing cutting-edge, quality, multidisciplinary care and [&hellip;]</p>

Share This Story

New Surgical Clinical Trial Recruiting Women with BRCA1 Mutations at High Risk for Ovarian Cancer

<p>A New Ovarian Cancer Clinical Trial at UT Health San Antonio MD Anderson Cancer Center is Investigating Efficacy of Surgical Pathways for Women Harboring High-Risk BRCA1 Genetic Mutations Women harboring mutations in the BRCA1 gene face an incredibly high risk of developing ovarian cancer during their lifetime and much higher risks for peritoneal cancer and [&hellip;]</p>

Share This Story

Subscribe to Cancer